Preventing Errors with Opiates: Identifying Risk and Choosing Effective Error Reduction Strategies

This on-demand webcast was originally presented live on November 6, 2010 in Philadelphia, Pennsylvania as part of the Pharmacy Learning Network Conference Series.

Cosponsored by North American Center for Continuing Medical Education, LLC and the University of Kentucky College of Pharmacy.

The University of Kentucky is an Equal Opportunity University

This activity was produced in conjunction with the Institute for Safe Medication Practices

Chair

Matthew Grissinger, RPh, FISMP, FASCP
Director, Error Reporting Programs
Institute for Safe Medication Practices
Horsham, Pennsylvania

Intended Learners

This activity is designed for health-system pharmacists.

Learning Objectives

After completing this activity, participants should be able to:

• Discuss common medication errors that are associated with the dosing and administration of opiates
• Describe methods to assess data and identify risks associated with the opiate-use process in your institution
• Select high-leverage error reduction strategies to reduce the risk associated with the use of opiates
• Identify measures to monitor the success of medication safety initiatives specific to opiates

Activity Overview

This on-demand webcast is available with synchronized slides and audio.

To be eligible for documentation of credit, participants must participate in the full activity, complete the 10-question online post-test with a score of 70% or better, and complete the evaluation form. After successful completion of the post-test and evaluation form online at www.naccme.com, participants may immediately print their documentation of credit.

There is no fee associated with this activity.

Participants who have successfully completed the live version of this activity are not eligible to receive credit for this enduring material.

Release Date: December 22, 2010

Expiration Date: December 22, 2011

Estimated time to complete: 1 hour

For questions regarding this educational activity, please call 609-371-1137.

Hardware/Software Requirements

All educational activities are accessible via a computer with 650 MHz PC, 128 MB RAM, Windows or MAC operating system, Internet Explorer, Netscape, or Safari browsers. Windows Media Player, sound card, and speakers are required for streamed audio. Flash Player, sound card, and speakers are required for video programs. A PDF reader is required for print publications. Please direct technical questions to webmaster@naccme.com.

CPE Accreditation

The University of Kentucky College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

This knowledge-based activity has been assigned UAN 022-999-10-007-H05-P and will award up to 1 contact hour (0.1 CEU) of continuing pharmacy education credit in states that recognize ACPE providers.

Statements of credit will indicate hours and CEUs based on participation and will be issued online at the conclusion of the activity. Successful completion includes completing the activity, its accompanying evaluation and posttest (score 70% or higher) and requesting credit online at conclusion of the activity. The College complies with the Accreditation Standards for Continuing Pharmacy Education.

Independent Clinical Reviewer: Patrick McDonnell, PharmD, Associate Professor of Clinical Pharmacy, Temple University School of Pharmacy, Philadelphia, Pennsylvania

Planning Committee

The planning committee comprises Matthew Grissinger, RPh, FISMP, FASCP, Patrick McDonnell, PharmD; Chris Dennison and Robbie Morgan, UK HealthCare CECentral, University of Kentucky; and Kristin Dickie, Mary Johnson, Rich Keenan, Nick Lombardi, Randy Robbin, and John Savage, NACCME.

Financial Disclosure and Conflicts of Interest

According to the disclosure policy of NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.

All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.

The faculty has reported the following:

Mr. Grissinger: Employee/Officer/Board member (spouse)—Johnson and Johnson

Dr. McDonnell: Consultant—Institute for Safe Medication Practices

Mr. Dennison, Ms. Dickie, Ms. Johnson, Mr. Keenan, Ms. Morgan, Mr. Robbin, and Mr. Savage have disclosed no relevant financial relationships with any commercial interests.

Mr. Lombardi: Stock shareholder—Inspire Pharmaceuticals, Inc, Vertex Pharmaceuticals, Inc, ViroPharma, Inc

NACCME requires faculty to inform participants whenever off-label/unapproved uses of drugs and/or devices are discussed in their presentations.

The faculty has disclosed that no off-label/unapproved use(s) of drugs and/or devices will be discussed.

Privacy Policy

NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. NACCME and our joint sponsors will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the appropriate accrediting agency.

NACCME maintains physical, electronic and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Copyright © 2010 by North American Center for Continuing Medical Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from North American Center for Continuing Medical Education.

Grant Support

Supported by an educational grant from Purdue Pharma L.P